A feasibility study to inform the design of a randomized controlled trial to identify the most clinically and cost effective Anticoagulation Length with low molecular weight heparin In the treatment of Cancer Associated Thrombosis (ALICAT): study protocol for a mixed-methods study

BACKGROUND: Venous thromboembolism is common in patients with cancer and requires anticoagulation with low molecular weight heparin. Current data informs anticoagulation as far as six months, yet guidelines recommend anticoagulation beyond six months in patients who have locally advanced or metastat...

Full beskrivning

Sparad:
Bibliografiska uppgifter
Huvudupphovsmän: Smith, Joanna D, Baillie, Jessica, Baglin, Trevor, Griffiths, Gareth O, Casbard, Angela, Cohen, David, Fitzmaurice, David A, Hood, Kerenza, Rose, Peter, Cohen, Alexander T, Johnson, Miriam, Maraveyas, Anthony, Bell, John, Toone, Harold, Nelson, Annmarie, Noble, Simon I
Materialtyp: Artigo
Språk:Inglês
Publicerad: BioMed Central 2014
Ämnen:
Study Protocol
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC4003288/
https://ncbi.nlm.nih.gov/pubmed/24726032
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1745-6215-15-122
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk